Evidence map›Paper›PMID 30894218›Full record

ArticleAlzheimer's research & therapy2019

Impact of a clinical decision support tool on prediction of progression in early-stage dementia: a prospective validation study.

Marie Bruun, Kristian S Frederiksen, Hanneke F M Rhodius-Meester, Marta Baroni, Le Gjerum, Juha Koikkalainen, Timo Urhemaa, Antti Tolonen, Mark van Gils, Daniel Rueckert and 13 more

Open access · goldAbstract readMulticenter StudyValidation Study
In one paragraph

Article in Alzheimer's research & therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it, 33 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. The Digitized Memory Clinic.Nature reviews. Neurology · 2024
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. cCOG: A web-based cognitive test tool for detecting neurodegenerative disorders.Alzheimer's & dementia (Amsterdam, Netherlands) · 2020
    Article
  19. Evaluating 2-[NeuroImage. Clinical · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 7 institutions in 5 countries.

Marie BruunDanish Dementia Research Centre, Neuroscience Centre, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, Denmark. marie.bruun@regionh.dk.ORCID 0000-0002-1066-1035
Kristian S FrederiksenDanish Dementia Research Centre, Neuroscience Centre, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, Denmark.
Hanneke F M Rhodius-MeesterAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Marta BaroniInstitute of Gerontology and Geriatrics, University of Perugia, Perugia, Italy.
Le GjerumDanish Dementia Research Centre, Neuroscience Centre, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, Denmark.
Juha KoikkalainenCombinostics Ltd., Tampere, Finland.
Timo UrhemaaVTT Technical Research Centre of Finland Ltd, Tampere, Finland.
Antti TolonenVTT Technical Research Centre of Finland Ltd, Tampere, Finland.
Mark van GilsVTT Technical Research Centre of Finland Ltd, Tampere, Finland.
Daniel RueckertDepartment of Computing, Imperial College London, London, UK.
Nadia DyremoseDanish Dementia Research Centre, Neuroscience Centre, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, Denmark.
Birgitte B AndersenDanish Dementia Research Centre, Neuroscience Centre, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, Denmark.
Afina W LemstraAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Merja HallikainenNeurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Sudhir KurlNeurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Sanna-Kaisa HerukkaNeurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Anne M RemesNeurology, Neuro Center, Kuopio University Hospital, Kuopio, Finland.
Gunhild WaldemarDanish Dementia Research Centre, Neuroscience Centre, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, Denmark.
Hilkka SoininenNeurology, Institute of Clinical Medicine, University of Eastern Finland, Kuopio, Finland.
Patrizia MecocciInstitute of Gerontology and Geriatrics, University of Perugia, Perugia, Italy.
Wiesje M van der FlierAlzheimer Center Amsterdam, Department of Neurology, Amsterdam Neuroscience, Vrije Universiteit Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
Jyrki LötjönenCombinostics Ltd., Tampere, Finland.
Steen G HasselbalchDanish Dementia Research Centre, Neuroscience Centre, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen University Hospital, Blegdamsvej 9, 2100, Copenhagen, Denmark.
University of Copenhagen · DKUniversity of Eastern Finland · FIAmsterdam Neuroscience · NLVTT Technical Research Centre of Finland · FIUniversity of Perugia · ITImperial College London · GBKuopio University Hospital · FI

Funding

European Commission 224328European Commission 601055European Commission 611005
6 · The paper itself

Abstract

backgroundIn clinical practice, it is often difficult to predict which patients with cognitive complaints or impairment will progress or remain stable. We assessed the impact of using a clinical decision support system, the PredictND tool, to predict progression in patients with subjective cognitive decline (SCD) and mild cognitive impairment (MCI) in memory clinics.

methodsIn this prospective multicenter study, we included 429 patients with SCD (n = 230) and MCI (n = 199) (female 54%, age 67 ± 9, MMSE 28 ± 2) and followed them for at least 12 months. Based on all available patient baseline data (demographics, cognitive tests, cerebrospinal fluid biomarkers, and MRI), the PredictND tool provides a comprehensive overview of the data and a classification defining the likelihood of progression. At baseline, a clinician defined an expected follow-up diagnosis and estimated the level of confidence in their prediction using a visual analogue scale (VAS, 0-100%), first without and subsequently with the PredictND tool. As outcome measure, we defined clinical progression as progression from SCD to MCI or dementia, and from MCI to dementia. Correspondence between the expected and the actual clinical progression at follow-up defined the prognostic accuracy.

resultsAfter a mean follow-up time of 1.7 ± 0.4 years, 21 (9%) SCD and 63 (32%) MCI had progressed. When using the PredictND tool, the overall prognostic accuracy was unaffected (0.4%, 95%CI - 3.0%; + 3.9%; p = 0.79). However, restricting the analysis to patients with more certain classifications (n = 203), we found an increase of 3% in the accuracy (95%CI - 0.6%; + 6.5%; p = 0.11). Furthermore, for this subgroup, the tool alone showed a statistically significant increase in the prognostic accuracy compared to the evaluation without tool (6.4%, 95%CI 2.1%; 10.7%; p = 0.004). Specifically, the negative predictive value was high. Moreover, confidence in the prediction increased significantly (∆VAS = 4%, p < .0001).

conclusionsAdding the PredictND tool to the clinical evaluation increased clinicians' confidence. Furthermore, the results indicate that the tool has the potential to improve prediction of progression for patients with more certain classifications.

Indexed as

Disease ProgressionAgedAged, 80 and overDecision Support Systems, ClinicalDementiaFemaleFollow-Up StudiesHumansMaleMiddle AgedNeuropsychological TestsPredictive Value of TestsProspective StudiesAlzheimer’s diseaseCDSSComputer-assistedConversionDementiaMild cognitive impairmentProgressionSubjective cognitive decline

Identifiers

PMID30894218
PMCPMC6425602
OpenAlexW2939345476

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.